Vijay Mahant received his M.S., Ph.D., and first post-doctorate from LUT (UK). He received his second post-doctorate from the UT Health Science Center at Houston/MD Anderson, TX, USA). Dr. Mahant is a scientist and an entrepreneur with more than 35 years of experience in immuno-and precision medicine (oncology, cardiology, pain management and psychiatry, etc.). His work in diagnostics has included the next generation TSH assay, PSA, Pharmacogenetics, cervical cancer (Human Papilloma Virus) and infectious diseases such as TB and Respiratory Virus Panel (common flu,and a number of coronaviruses) . He held senior positions at Nicholas Institute/ Quest and executive positions at Qualigen and AGI.. He is a founder/co-founder of diagnostic companies such as MediLite. Dr. Manhunt has been involved in fund-raising (about $140 million), Initial Public Offerings (IPOs), including an acquisition. Dr. Mahant is currently the CSO of Oncology Pharma (contract will expire in October 2020). Oncology Pharma is focused on “targeted” chemos and bio-pharmaceutical based drugs “soft biopsies”, including precision oncology combined with artificial intelligence and machine learning. He is a former VP, Precision oncology, Batu Biologics (cellular antiangiogenic vaccine) and in addition, he served on SAB/MAB of Batu Biologics. Dr. Mahant is currently on the advisory board of several young biotech companies such as Trutino BioSciences (an oncology company developing IL-2 based drugs), and Immunicom (a cancer therapeutic device company) , including an oncology hospital (Chipsa) and United Cancer Center (Outpatient clinic, expected to be in operation in summer 2020) Dr. Mahant has 30 issued patents and five patents pending; he has authored and/or co-authored publications in journals and science books; he is the Section Editor for the “Echo System of Translational Medicine, Journal of Translational Medicine.

Professor Adel Ekladious is a senior medical consultant with an extensive experience in general and acute medicine, he is a fellow of few colleges which includes Australia, Glasgow, Ireland, London and America, he worked as a clinical director of medicine and director of physician training. He served in the Panel of the medical Board in Western Australia, his research includes stroke, general neurology, chronic hepatitis, general hepatology, pulmonary hypertension, heart failure and rare diseases.

Dr. Shigeo Masuda received his MD from the University of Tokyo in 1996, and PhD in Hematology/Oncology from the Graduate School of Medicine, University of Tokyo, Japan. He was an Assistant Professor and an Associate Professor at Jichi Medical University, Japan, from 2007 to 2012, and joined RIKEN CDB in 2011. He studied at the Belmonte Lab in the Salk Institute from 2012 to 2014. Currently, he is an Associate Professor of Cardiovascular Surgery in Osaka University, Japan. His interest is regenerative medicine using iPS-derived cells, including molecular targeted therapy for iPS-derived undifferentiated cells to improve safety.

Field of expertise in Molecular Targeted Therapy,Induced Pluripotent Stem Cell and Regenerative Medicine.

(Sorush Niknamian PhD MRSB FChE FNNECOS FTSCO ANCC, AANP, ACPE, ACHE, ADA CERP APA FMDCSCO) Ph.D. in Cell and Molecular Biology and Oncology and Professor of Cell and Molecular Biology, Oncology and Biological Attacks. He is a Professional Biologist, Senior Research Scientist, Chartered Scientist and Registered Scientist at Violet Cancer Institute (VCI). His Science Council ID is: A-0008833. He is one of United Kingdom and Indiana Cancer Consortium (ICC) certified. He is a Registered Researcher in the U.S. Government's System for Award Management, Registered Scientist at National Center for Biotechnology Information. He is studying Medicine/Military Medicine at Liberty University (LU), Lynchburg, VA, United States of America. He holds Bachelor’s Degree in Mechatronics Engineering, applied Mathematics, Civil Engineering and Management. He is a Member of US Government National Science Foundation, Member of Hera Swiss Volunteers (ID: 198036), Member of US Army American College of Physicians Chapter, Ambassador of American Cancer Society (ACS CAN) and former Ambassador of European Association for Cancer Research (EACR), Active Member of Federal Health Professionals at US Army Forces and Certified Member of American Red Cross and Food Regulatory Affairs Professionals. He is a Board Member and contributor of Weston A Price Foundation co-founded in 1999 by Sally Fallon (Morell) and nutritionist Mary G. Enig. PhD. He Holds Honorary Doctorate of Cancer Biology and Doctor of Science from Violet Cancer Institute. He is preserved and nominated for the preserved as Position Title: DIRECTOR OF MILITARY SUPPORT, Agency: Army National Guard Units. Announcement Number: ID: WA-10507254-AR-19-161. Extra Information: DIRECTOR OF MILITARY SUPPORT located at the WASHINGTON J3 DCSOPS. Professor Sorush Niknamian is an ACP Chapter member in United States Army and Air Force. Active Member of IMRTC-USA (International Management Research and Technology Consortium Research) as Advisor, Referee, Professor at IMRTC-USA (International Management Research and Technology Consortium Panel. He is a Service Member of Modern Military Association of America. Certified Member of World Medical Association with ID: 5c7b154b01602 as a Junior Medical Doctor. He is an Active Member of the National Guard Association of the United States of America (Branch: Army, Rank: Major, State Affiliation: Maryland and Serving Volunteer at the Peace Corps of the United States of America (Ref ID: 10811430) and certified member of The National Bureau of Asian Research. He is a member of Military Officers Association of America (Member Number: 05670401, Rank: Major).

Amgad Mohammed Rabie Hamed Fouda has completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers and scientists. His new researches focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published more than 25 papers in very reputed journals and serving as an Editorial Board Member of great repute. 

Mrs Despoina Pantazi graduated from the Faculty of Chemistry at the University of Ioannina (UOI) in Greece, where she received her Master’s (2003) and PhD (2008) degrees in Biochemistry. Since 2018 she has been an academic staff (LTS class A, permanent staff) at the Laboratory of Biochemistry and Clinical Chemistry at the Faculty of Chemistry, UOI. She is also a partner at the Atherothrombosis Research Center (ARC) of the Network of Research Support Laboratories at the UOI (from 2021) (https://atherothrombosis.lab.uoi.gr). Cognitive object “Biochemistry”. She taught 3rd and 4th-year undergraduate courses in the Faculty of Chemistry (Clinical Chemistry, Introduction to Clinical Biochemistry, Biochemistry Laboratory, Advanced Biochemistry Laboratory, etc.) and the postgraduate course “Medical Chemistry”, most recently until 2023.

She received a two-month Scientific leave abroad (June-July 2024) for a research collaboration at the Institut Sant Pau of the Universitat Autónoma de Barcelona (UAB) in Spain. She has participated in research programs (additional employment). She has been a scholarship holder of the Erasmus Staff Training program four times and she received fellowships from SSF and FEBS, 4 awards for presentations, 1 commendation for a work presentation and an award from the Academy of Athens. She publishes in international journals (https://orchid.org/0000-0001-6636-5959) and organized and presented 5 webinars. She is also co-author of chapters in two books (“Kallipos-Open Scientific Books” ΙSBN: 978-618-228-225-0 and a book in a global edition, ISBN: 978-81-308-0343-2). Invited speaker at Greek conferences. Reviewer of articles in Greek and international journals (more than 50 reviews in 22 journals). She has participated in Greek and international conferences with more than 80 abstracts. She supervised 13 bachelor's theses and was a member of a three-person commission for a master's thesis, as also the supervisor of a master's thesis. She is currently the supervisor of two master's theses.

Member of the Steering Committee of the Institute for Study and Education in Thrombosis and Antithrombotic Education (ISETAT, www.imetha.gr/en) for the period 10/2022-10/2024 and 10/2024-10/2026. Member of Greek scientific societies (HSBMB, AGC board member in 2 working groups, HAS and member in 1 working group) as well as in international scientific organisations (EMLTD, EAS, ΕSC- member in 3 working groups and ISTH Academy).

Eduardo Domínguez-Adame Lanuza studied for a degree in Medicine and Surgery at the University of Seville, 1983-89. He was a Resident Physician by competitive examination in the specialty of General and Digestive Surgery at the Virgen del Rocío University Hospital in Seville (1991-95), obtaining the title of Specialist Physician in General and Digestive Surgery. He holds a PhD from the University of Seville with a grade of Outstanding Cum Laude by unanimous vote (2009). In his medical career, he has held a position as Area Specialist Physician, in chronological order, at the Virgen Macarena University Hospital in Seville, the Merced Hospital in Osuna (Seville), the General Hospital of Jerez de la Frontera (Cádiz) and the Virgen Macarena University Hospital in Seville. Since 2005 he has held the position of Statutory Area Specialist Doctor at the Virgen Macarena University Hospital through a national competitive examination. In the field of healthcare management, he has been Coordinator of the Advanced Laparoscopic Surgery Unit of the General Surgery and Digestive System Service at the Hospital of Jerez de la Frontera (Cádiz). At this hospital he has been a member of the Hospital Ethics and Research Committee. Since 2008 he has been Head of Section through a competitive examination at the Virgen Macarena University Hospital in Seville. He is responsible for the Esophagogastric, Metabolic and Advanced Laparoscopic Surgery Unit of the General Surgery and Digestive System Service at the Virgen Macarena University Hospital. He is a member of various Hospital Clinical Commissions (Ethics and Research, Bariatric, Mortality and Autopsies, Pharmacy and Therapeutics, Esophageal-Gastric Tumors) of the Virgen Macarena University Hospital in Seville. He has been a member of the evaluation committee for intermediate management positions in the Andalusian Health Service. His administrative, teaching, clinical and care management in the Esophageal-Gastric, Metabolic and Advanced Laparoscopy Surgery Unit has been consecutively evaluated as excellent by the Quality Subdirectorate of the Management of the Virgen Macarena University Hospital in Seville. From the hospital teaching point of view, he has been a Tutor of Residents in the Specialty of General Surgery and the Digestive System at the Virgen Macarena University Hospital in Seville. He has been an Honorary Collaborating Professor of the Department of Surgery at the University of Seville from 1991 to 1996. Since 2007 he has been a Clinical Associate Professor (ACIS), by competitive examination, of the Department of Surgery at the University of Seville, teaching uninterruptedly at the Centers; Faculty of Medicine and Faculty of Dentistry of the University of Seville. He is currently Associate Professor of the Department of Surgery at the University of Seville, competitive examination prior to accreditation, since April 24, 2024. He has been Coordinator in Charge of the Optional Subject Morbid Obesity. Director of multiple Advanced Studies Diplomas (DEAs), Tutor of Master's Final Projects and Final Degree Projects at the Faculty of Medicine of the University of Seville. His teaching activity has been positively evaluated by both students and the University of Seville. To date, Director of 7 Doctoral Theses, 4 pending defense and reading. He has been a member of Doctoral Thesis Tribunals. He has also been a Professor of the Master in Endoscopic Surgery organized by the University of Granada and by IAVANTE – Health Department of the Junta de Andalucía. He has been a member of the CTS-348 Research Group (formerly 3306 of the Health Department of the Junta de Andalucía). He is currently a research member of the CTS-544 Research Group participating in several research projects subsidized by the Health Department of the Junta de Andalucía, Ministry of Health and Consumption. His Research Lines are: Portal Hypertension, Morbid Obesity Surgery, Functional and Neoplastic Pathology Surgery of the Esophagus, Inflammatory Response. He has carried out stays in National and Foreign Centers, highlighting those carried out at the St. Mark's Hospital (Prof. RJ Nicholls) in London in the United
Kingdom, whose objective has been the improvement in diagnostic-therapeutic techniques in coloproctological surgery, with the obtaining of a Certificate in Coloproctology (St. Mark's Hospital, London University), as well as the one carried out at the Regional University Hospital Center of Montpellier - Hôpital Saint Eloi (Prof. JM Fabre, University of Montpellier) in France, whose objective has been the improvement in diagnostic-therapeutic, laparoscopic and thoracoscopic surgical techniques in esophageal-gastric care processes. Director of National and International Surgery Courses carried out jointly by the University of Seville (Department of Surgery) and the Andalusian Health Service, which have been accredited by Scientific Societies (Andalusian Association of Surgeons, Spanish Association of Surgeons, Spanish Society of Bariatric Surgery and Associated Metabolic Diseases, among others) and by the Health Quality Agency of Andalusia (ACSA). He has been General Director of Teaching and Academic Training of the Royal and Illustrious College of Physicians of Seville, and is a Member of the Committee of Scientific Experts of said Institution. He is a Corresponding Academician of the Royal Academy of Medicine and Surgery of Seville and an elected member of the Board of Trustees of its Foundation. He has published 184 articles in national and international journals. Reviewer for the Spanish Journal of Surgery, the Spanish Journal of Digestive Diseases, the Andalusian Journal of Digestive Pathology, the Andalusian Surgery Journal, the Ibero-American Bariatric & Metabolic Journal, the Annals of Mediterranean Surgery and the Spanish Journal of Public Health. He has participated in 232 invited presentations and/or conferences, as well as 409 contributions to national and international scientific conferences and meetings. He has participated in the writing of 30 books and/or book chapters.
He has obtained recognition with national and international awards for his research activity (Spanish Association of Surgeons, Andalusian Association of Surgeons, Andalusian Society of Digestive Pathology, Royal and Illustrious Official College of Physicians of Seville, Royal Academy of Medicine and Surgery of Seville-University of Seville, Spanish Association of Video-Surgery, Baxter Prize). Diploma of Competencies, as well as the Diploma of Expert in Bariatric and Metabolic Surgery endorsed by the Spanish Society of Bariatric Surgery and Associated Metabolic Diseases (SECO) as well as by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Member of the Andalusian Association of Surgeons (ASAC), Spanish Association of Surgeons (AEC), Spanish Society for Obesity Surgery and Metabolic Diseases (SECO), holding positions in different sections of the same. Quality Accreditation EXPERT Level by the Health Quality Agency of the Andalusian Government.
He is currently a full-time Professor of Surgery at the University of Seville linked to the Virgen Macarena University Hospital in Seville.
ORCID https://orcid.org/0000-0002-0116-9663
CLARIVATE Web of Science ResearcherID: AAJ-4061-2020
SCOPUS 56005379300
GOOGLE SCHOLAR JENmA6gAAAAJ
DIALNET 1144962
IDUS 1118
SISIUS 16377